The US Food and Drug Administration recently approved an implantable heart failure monitoring device, Cardio MEMS HF System, which has been designed to reduce hospital admissions.
The goal of this first-of-its-kind implantable wireless device with remote monitoring of pulmonary artery (PA) pressure is to reduce heart failure-related hospitalizations.Heart failure (HF) is one of the most common reasons for hospitalizations for people aged 65 and older.
At present, patients who have been hospitalized with worsening HF undergo an invasive procedure called a right-heart catheterization to measure PA pressures. The CardioMEMS HF System provides the same information as a right-heart catheterization, but without the invasive procedure, the company claims.
